Focuses on supporting the cutting-edge drug discovery technologies of academia, research institutes, pharmaceutical companies and other organizations from the startup stage. Primarily invests in Japanese drug discovery seeds to commercialize them. Leverages its overseas investment infrastructure and network to invest in early-stage global drug discovery startups.
Invests in large- and mid-sized listed companies in Japan and develops trusted relationships with the management teams of investee companies to support management initiatives aimed at long-term, sustainable growth and enhanced corporate value. As a major shareholder in investee companies, seeks to encourage them to take healthy risks and invest in growth, adopting a sustainable approach to enhance their corporate value and improving their key performance metrics to foster the development of corporate activities of the large- and medium-sized Japanese companies that drive the Japanese economy, and to create a virtuous cycle for the broader Japanese economy.